CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
28.67
+0.65 (2.32%)
Dec 20, 2024, 4:00 PM EST - Market closed
CG Oncology Employees
CG Oncology had 61 employees as of December 31, 2023.
Employees
61
Change
n/a
Growth
n/a
Revenue / Employee
$11,213
Profits / Employee
-$1,290,672
Market Cap
1.94B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UFP Technologies | 3,093 |
| Amphastar Pharmaceuticals | 1,761 |
| Galapagos NV | 1,123 |
| Supernus Pharmaceuticals | 652 |
| ImmunityBio | 628 |
| MannKind | 414 |
| Harmony Biosciences Holdings | 246 |
| Disc Medicine | 74 |
CGON News
- 5 days ago - CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 8 days ago - CG Oncology: Positive Phase 3 Outcome Could Lead To BLA Of Cretostimogene - Seeking Alpha
- 9 days ago - CG Oncology Announces Pricing of Public Offering - GlobeNewsWire
- 10 days ago - CG Oncology Announces Proposed Public Offering - GlobeNewsWire
- 15 days ago - Health Rounds: Experimental CG Oncology immunotherapy shows promise in bladder cancer - Reuters
- 15 days ago - SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award - GlobeNewsWire
- 16 days ago - Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - GlobeNewsWire
- 4 months ago - CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire